Meta AnalysisID 6586

中药方剂与中成药联合熊去氧胆酸治疗妊娠期肝内胆汁淤积症疗效比较:网状Meta分析

CRD42020188831

Compared with ursodeoxycholic acid alone, the effect of ursodeoxycholic acid combined with Chinese prescriptions or patent medicine for cholestasis during pregnancy. In addition, which is the best treatment option?

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Formula: 1Meta-analysis: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final meta_analysis record.

Meta Analysis Id
6586
Evidence Id
15144
Core Evidence Id
15144
Source Meta Analysis Id
6568
Herb2 Meta Analysis Id
HBMA006568
Crd Id
CRD42020188831
Title
Comparison of Chinese prescriptions and patent medicine combine with UDCA in the treatment efficacy of cholestasis during pregnancy: a network meta-analysis
Review Question
Compared with ursodeoxycholic acid alone, the effect of ursodeoxycholic acid combined with Chinese prescriptions or patent medicine for cholestasis during pregnancy. In addition, which is the best treatment option?
Study Type Included
We will include in the related clinical randomized controlled trial.
Condition Being Studied
Cholestasis of pregnancy is a complication occurring during pregnancy, mainly in the middle and later stages of pregnancy.The disease can lead to premature delivery, amniotic fluid pollution, neonatal asphyxia, neonatal pneumonia and a series of adverse perinatal outcomes.At the same time, studies have found that women with a history of ICP have a higher risk of cholelithiasis, cholecystitis, hypothyroidism, pancreatic disease and digestive disease
Participant
Inclusion: 1.The patient has itchy skin as the main symptom during pregnancy. 2.The level of related indicators including ALT (alanine aminotransferase), AST (aspartate transaminase), TBA ( total biliary acid) increased. Exclusion: Other liver and gallbladder diseases such as viral hepatitis.
Animal
Human Disease Modelled
Intervention
Accoding to the treatment option, there are 6 interbentions including B: yinzhihuang oral liquid + UDCA; C: salvia injection + UDCA; D: yinchenhao decoction (yinchen > 15g, zhizi > 9g, dahunag > 5g) + UDCA; E: the change of yinchenhao decoction 1 (yinchen > 15g, zhizi < 9g, dahunag > 5g) + UDCA; F: the change of yinchenhao decoction 2 (yinchen > 15g, zhizi > 9g, dahunag < 5g) + UDCA; G: the change of yinchenhao decoction 3 (yinchen > 15g, zhizi < 9g, dahunag < 5g) + UDCA; H: other Traditional Chinese Medicine prescriptions (yinchen < 15g, zhizi < 9g, dahunag < 5g) + UDCA.
Comparator Control
The treatment option A: using UDCA (ursodeoxycholic acid) alone was as the control group.
Main Outcome
Main outcome include in pruritus score which is based on the standards set by Ribalta and the level of ALT (alanine aminotransferase), AST (aspartate transaminase), TBA ( total biliary acid). Measures of effect Mean differences is our main effect measure.
Outcome Measure
Additional Outcome
None. Measures of effect None.
Study Method
Meta-analysis, Systematic review
Keyword
China; Cholestasis, Intrahepatic; Female; Humans; Network Meta-Analysis; Nonprescription Drugs; Pregnancy; Prescriptions; Treatment Outcome
Contact
Yin Xiao Jiang [email protected]
Organisational Affiliation
Chengdu University of Traditional Chinese Medicine
Funding Source
Sichuan Science and Technology Program (2019YJ0492)
Other Selection Criteria
Final Publication
Same Topic Review
Published Protocol
Review Type
Language
English
Country
China
Review Stage
Review Ongoing
First Submission Date
2020-08-09
Registration Date
2020-09-09
Anticipated Start Date
2020-08-09
Anticipated Completion Date
2020-09-10
Title Cn
中药方剂与中成药联合熊去氧胆酸治疗妊娠期肝内胆汁淤积症疗效比较:网状Meta分析
Title En
Comparison of Chinese prescriptions and patent medicine combine with UDCA in the treatment efficacy of cholestasis during pregnancy: a network meta-analysis
Bilingual Status
complete